- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Apr 27, 2026 | 24.23M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 25.19M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 25.18M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 24.83M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 25.84M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $50.08M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $56.93M |
| Capex | Q3 2026 · Mar 31, 2026 | $74.53M |
| Capex | Q3 2026 · Mar 31, 2025 | $68.21M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $173.2M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $190.6M |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $1.58B |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $1.58B |
| Short Term Debt | Q3 2026 · Mar 31, 2026 | $13.83M |
| Short Term Debt | Q3 2026 · Jun 30, 2025 | $9.09M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $189M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $233.98M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$524.1M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$530.73M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$571.26M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$583.49M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$557.52M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$554.47M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | −$570.99M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$550.15M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $730M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $758.66M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $2.51B |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $2.53B |
| Current Assets | Q3 2026 · Mar 31, 2026 | $495.81M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $502.61M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $2.05B |
| Total Assets | Q3 2026 · Jun 30, 2025 | $1.97B |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.55 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $2.81 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.33 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $1.56 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.57 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $2.89 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.33 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $1.61 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $58.92M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $173.11M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $50.55M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $159.42M |
| Net Income | Q3 2026 · Mar 31, 2026 | $13.84M |
| Net Income | Q3 2026 · Mar 31, 2026 | $70.82M |
| Net Income | Q3 2026 · Dec 31, 2025 | $49.34M |
| Net Income | Q3 2026 · Sep 30, 2025 | $7.64M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$8.24M |
| Net Income | Q3 2026 · Mar 31, 2025 | $40.27M |
| Net Income | Q3 2026 · Dec 31, 2024 | $61.06M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$12.55M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $49.17M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $186.24M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $40.54M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $160.83M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $477.01M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.49B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $416.96M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $1.33B |
| Revenue | Q3 2026 · Mar 31, 2026 | $886.21M |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.79B |
| Revenue | Q3 2026 · Mar 31, 2025 | $789.47M |
| Revenue | Q3 2026 · Mar 31, 2025 | $2.53B |